Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The AMP-activated protein kinase gamma 1 subunit (PRKAG1) is a regulatory component of the AMPK complex, a central energy sensor and regulator of cellular metabolism. It senses intracellular levels of AMP/ADP versus ATP, promoting activation of the catalytic α-subunit when energy is low. This leads to phosphorylation events that inhibit anabolic processes and stimulate catabolic pathways. PRKAG1 is crucial for metformin-mediated suppression of hepatic glucose production and is implicated in metabolic diseases.
Metformin-mediated suppression of hepatic glucose production via AMPK activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-AMP-activated protein kinase subunit gamma-1 (PRKAG1).